DK210888A - Fremgangsmaade til fremstilling af en hoejresmeltende polymorf form af terfenadin - Google Patents

Fremgangsmaade til fremstilling af en hoejresmeltende polymorf form af terfenadin

Info

Publication number
DK210888A
DK210888A DK210888A DK210888A DK210888A DK 210888 A DK210888 A DK 210888A DK 210888 A DK210888 A DK 210888A DK 210888 A DK210888 A DK 210888A DK 210888 A DK210888 A DK 210888A
Authority
DK
Denmark
Prior art keywords
terfenadine
preparing
procedure
polymorph form
approx
Prior art date
Application number
DK210888A
Other languages
English (en)
Other versions
DK210888D0 (da
DK173555B1 (da
Inventor
Timothy G Fawcett
Christian T Goralski
David W Ziettlow
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8198929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK210888(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK210888D0 publication Critical patent/DK210888D0/da
Publication of DK210888A publication Critical patent/DK210888A/da
Application granted granted Critical
Publication of DK173555B1 publication Critical patent/DK173555B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198802108A 1986-05-07 1988-04-18 Fremgangsmåde til fremstilling af en ren polymorf form af terfenadin DK173555B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86061986A 1986-05-07 1986-05-07
US86061986 1986-05-07
EP88106898 1988-04-29
EP88106898A EP0339118B1 (en) 1988-04-29 1988-04-29 Preparation of polymorphically pure terfenadine

Publications (3)

Publication Number Publication Date
DK210888D0 DK210888D0 (da) 1988-04-18
DK210888A true DK210888A (da) 1989-10-19
DK173555B1 DK173555B1 (da) 2001-03-12

Family

ID=8198929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198802108A DK173555B1 (da) 1986-05-07 1988-04-18 Fremgangsmåde til fremstilling af en ren polymorf form af terfenadin

Country Status (8)

Country Link
US (1) US4742175A (da)
EP (1) EP0339118B1 (da)
AR (1) AR243612A1 (da)
AT (1) ATE107283T1 (da)
CA (1) CA1312610C (da)
DE (1) DE3850244T2 (da)
DK (1) DK173555B1 (da)
ES (1) ES2056851T3 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
IT1217837B (it) * 1988-06-17 1990-03-30 Lepetit Spa Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/piperidinbutanolo"
IL93499A0 (en) * 1989-02-28 1990-11-29 Merrell Dow Pharma Preparation of the low melting polymorphic form of terfenadine
CA2015390A1 (en) * 1989-05-01 1990-11-01 Frederick J. Mccarty Process for the preparation of the high melting polymorphic of terfenadine
US5247092A (en) * 1989-12-29 1993-09-21 Erregierre Industria Chimica S.P.A. Preparation of the high-melting polymorph of terfenadine
FR2681861B1 (fr) * 1991-10-01 1995-06-09 Isochem Sa Procede de preparation d'une forme polymorphique de la terfenadine, a point de fusion eleve, d'une plus grande purete et produit obtenu.
US5347006A (en) * 1992-12-31 1994-09-13 Augusto Lavacchielli Method of preparing a polymorph of terfenadine
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
EP1369409B1 (en) 1993-06-24 2006-04-05 AMR Technology, Inc. Process for preparing compounds useful as intermediates
DK0705245T3 (da) 1993-06-25 2003-04-14 Merrell Pharma Inc Nye mellemprodukter til fremstilling af antihistaminiske 4-diphenylmethyl/diphenylmethoxy-piperidinforbindelser
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
IT1270829B (it) * 1993-09-17 1997-05-13 Recordati Chem Pharm Procedimento per la preparazione di polimorfo i della terfenadina con distribuzione granulometrica ottimale
EP1178041A1 (en) * 1994-05-18 2002-02-06 Aventis Pharmaceuticals Inc. Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
US6201124B1 (en) * 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
JP2009514969A (ja) 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA728544B (en) * 1972-01-28 1974-02-27 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine

Also Published As

Publication number Publication date
EP0339118A1 (en) 1989-11-02
ATE107283T1 (de) 1994-07-15
DK210888D0 (da) 1988-04-18
EP0339118B1 (en) 1994-06-15
DE3850244T2 (de) 1994-10-06
US4742175A (en) 1988-05-03
AR243612A1 (es) 1993-08-31
ES2056851T3 (es) 1994-10-16
CA1312610C (en) 1993-01-12
DE3850244D1 (de) 1994-07-21
DK173555B1 (da) 2001-03-12

Similar Documents

Publication Publication Date Title
DK210888A (da) Fremgangsmaade til fremstilling af en hoejresmeltende polymorf form af terfenadin
SU976847A3 (ru) Способ получени производных 1-фенил-2,3,4,5-тетрагидро-1н-3-бензазепина или их солей
KR880002847A (ko) 형태학적으로 균일한 형태를 갖는 티아졸 유도체의 제조방법
SU496730A3 (ru) Способ получени производных изоиндолина или их солей
JPS6471816A (en) Pharmacologically useful polymetamorphosis of buspirone
SU474981A3 (ru) Способ получени 9(1-замещенный-4пиперидилиден)-тиоксантенов или их солей
US4727147A (en) Optically active 1-(4-methoxybenzyl)-1,2,3,4,5,6,7,8-octahydroisoquinolinium acetates
KR870005949A (ko) 비스페놀 a의 재결정화 방법
SU1151205A3 (ru) Способ получени 2-амино-4,6-диметоксипиримидина
Englert et al. The Bromination of PYRIDINE1
SU692561A3 (ru) Способ получени производных 2нитро-8-фенилбензофурана
Takano et al. Efficient synthesis of tryptamine
US3055888A (en) 2-alkylmercapto-9-[2'-(n-alkylpiperidyl-2" and pyrrolidyl-2")-ethylidene-1']-thiaxanthenes
NO124687B (da)
SU1491336A3 (ru) Способ получени кристаллического моногидрата 1-/3Ъ4Ъ-диэтоксибензил/-6,7-диэтокси-3,4-дигидроизохинолиний-теофиллин-7-ацетата или 1-/3Ъ,4Ъ-диэтоксибензил/-6,7-диэтокси-3,4-дигидроизохинолинийтеофиллин-7-ацетата
SU719507A3 (ru) Способ получени винкаменина или его солей, или его четвертичных солей, или его молекул рных соединений
US3413346A (en) 2-(2-haloethylamino)-5-halo-benzophenones
NO165419B (no) Innretning for laasing og frigjoering av gjenstander beregnet for offentlig bruk, saasom bagasjetraller.
Reed et al. 108. Reaction of benzthiazole derivatives. Part II. The conversion of 1-alkylthiobenzthiazoles into 1-thio-2-alkyl-1: 2-dihydrobenzthiazoles
Ismail et al. Reactions with 3, 1-benzoxazin-4-ones. 3. Reactions of 6, 8-dibromo-2-methyl-3, 1-benzoxazin-4-ones with amines
NO783770L (no) Nye derivater av isokinolin.
SU442601A1 (ru) Способ получени производных азепина
JPS5534115A (en) Crystallization method
US4439611A (en) Isolation of [S-(R*, S*]-1-(3-acetylthio-3-benzoyl-2-methylpropionyl)-L-proline from a diastereomeric mixture
RU2043993C1 (ru) Способ получения гексагидрата тринатрийфосфоноформиата

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired